Literature DB >> 12684921

Decrease in human immunodeficiency virus type 1 load during acute dengue fever.

George Watt1, Pacharee Kantipong, Krisada Jongsakul.   

Abstract

Rather than the expected increase in human immunodeficiency virus type 1 (HIV-1) load, there was transient suppression of HIV-1 replication during acute dengue infection in a 29-year-old Thai woman. Acute-phase (but not convalescent-phase) serum samples obtained from an HIV-1-uninfected patient with dengue fever reduced HIV-1 infectivity, as determined by a peripheral blood mononuclear cell assay, suggesting the possibility that HIV-1 replication is suppressed during acute dengue fever, as occurs during some cases of scrub typhus infection and measles.

Entities:  

Mesh：

Year:  2003        PMID： 12684921     DOI： 10.1086/374600

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  25 in total

1.  In vitro suppression of human immunodeficiency virus type 1 replication by measles virus.

Authors:  Mayra García; Xiao-Fang Yu; Diane E Griffin; William J Moss
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

2.  Dengue virus serotype 1 non-structural protein NS5 expression interferes with HIV replication in a CD4+ T-cell line.

Authors:  Uriel A López-Lemus; Clemente Vásquez; Roberto Vázquez-Campuzano; Salvador Valle-Reyes; Carmen Guzmán-Bracho; Diego Araiza-Garaygordobil; Nicte Rebolledo-Prudencio; Iván Delgado-Enciso; Francisco Espinoza-Gómez
Journal:  Am J Trop Med Hyg       Date:  2014-01-27       Impact factor: 2.345

3.  Dengue Infection in a Human Immunodeficiency Virus-1 Positive Patient Chronically Infected with Hepatitis B Virus in Western Mexico.

Authors:  Iván Delgado-Enciso; Francisco Espinoza-Gómez; Rodolfo Ochoa-Jiménez; Salvador Valle-Reyes; Clemente Vásquez; Uriel A López-Lemus
Journal:  Am J Trop Med Hyg       Date:  2016-11-28       Impact factor: 2.345

4.  Dengue Virus Coinfection in Human Immunodeficiency Virus-1-Infected Patients on the West Coast of Mexico.

Authors:  Francisco Espinoza-Gómez; Iván Delgado-Enciso; Salvador Valle-Reyes; Rodolfo Ochoa-Jiménez; Conrado Arechiga-Ramírez; José L Gámez-Arroyo; Roberto Vázquez-Campuzano; Carmen Guzmán-Bracho; Clemente Vásquez; Uriel A López-Lemus
Journal:  Am J Trop Med Hyg       Date:  2017-07-19       Impact factor: 2.345

5.  Abstracts of the HIV Drug Therapy in the Americas 8-10 May 2014, Rio de Janeiro, Brazil.

Authors: 
Journal:  J Int AIDS Soc       Date:  2014-05-07       Impact factor: 5.396

6.  Significantly reduced CCR5-tropic HIV-1 replication in vitro in cells from subjects previously immunized with Vaccinia Virus.

Authors:  Raymond S Weinstein; Michael M Weinstein; Kenneth Alibek; Michael I Bukrinsky; Beda Brichacek
Journal:  BMC Immunol       Date:  2010-05-18       Impact factor: 3.615

7.  Contrasting roles for TLR ligands in HIV-1 pathogenesis.

Authors:  Beda Brichacek; Christophe Vanpouille; Yana Kiselyeva; Angelique Biancotto; Melanie Merbah; Ivan Hirsch; Andrea Lisco; Jean Charles Grivel; Leonid Margolis
Journal:  PLoS One       Date:  2010-09-20       Impact factor: 3.240

8.  Viruses within the Flaviviridae decrease CD4 expression and inhibit HIV replication in human CD4+ cells.

Authors:  Jinhua Xiang; James H McLinden; Robert A Rydze; Qing Chang; Thomas M Kaufman; Donna Klinzman; Jack T Stapleton
Journal:  J Immunol       Date:  2009-12-15       Impact factor: 5.422

9.  Inhibition of HIV-1 infection by monoclonal antibodies to carbohydrates of Schistosoma mansoni.

Authors:  Marco Antônio Gomes Mello; Rita Elizabeth Mascarenhas; Geraldo Argolo Ferraro; Donald Harn; Marco Galvão-Castro; Dumith Chequer Bou-Habib
Journal:  Med Microbiol Immunol       Date:  2005-01       Impact factor: 3.402

Review 10.  Bottlenecks in HIV-1 transmission: insights from the study of founder viruses.

Authors:  Sarah B Joseph; Ronald Swanstrom; Angela D M Kashuba; Myron S Cohen
Journal:  Nat Rev Microbiol       Date:  2015-06-08       Impact factor: 60.633
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.